We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

88 hedge funds and large institutions have $176M invested in BioSpecifics Technologies Corp. in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 34 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 87 → 88 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 34

6% less capital invested

Capital invested by funds: $187M → $176M (-$11.3M)

Holders
88
Holders Change
+1
Holders Change %
+1.15%
% of All Funds
2%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
33
Reduced
34
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$7.85M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.43M
3
AQR Capital Management
AQR Capital Management
Connecticut
+$837K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$671K
5
ACM
Ativo Capital Management
Illinois
+$472K

Top Sellers

Rank Fund Capital Flow
1
NC
Northpointe Capital
Michigan
-$2.47M
2
EAM
Eagle Asset Management
Florida
-$2.32M
3
CCM
Cadence Capital Management
Massachusetts
-$1.38M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$813K
5
AllianceBernstein
AllianceBernstein
Tennessee
-$794K
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$1.75M -$552K -12,282 -23%
OAM
27
Oxford Asset Management
United Kingdom
$1.65M -$267K -5,941 -14%
NI
28
Numeric Investors
Massachusetts
$1.61M -$157K -3,500 -9%
ACM
29
Ativo Capital Management
Illinois
$1.43M +$472K +10,504 +46%
Deutsche Bank
30
Deutsche Bank
Germany
$1.39M +$302K +6,709 +26%
CAM
31
ClariVest Asset Management
California
$1.36M +$296K +6,580 +27%
First Manhattan
32
First Manhattan
New York
$1.31M -$220K -4,900 -14%
Morgan Stanley
33
Morgan Stanley
New York
$1.24M +$340K +7,571 +36%
TCIM
34
TIAA CREF Investment Management
New York
$1.1M -$110K -2,442 -9%
AL
35
AJO LP
Pennsylvania
$854K +$394K +8,765 +80%
IP
36
Isthmus Partners
Wisconsin
$754K +$29.4K +653 +4%
SCA
37
Secor Capital Advisors
New York
$730K -$4.99K -111 -0.7%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$727K – – –
Two Sigma Investments
39
Two Sigma Investments
New York
$707K +$422K +9,382 +135%
Millennium Management
40
Millennium Management
New York
$690K +$332K +7,396 +87%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$667K -$27K -600 -4%
DCM
42
Dupont Capital Management
Delaware
$664K – – –
SO
43
STRS Ohio
Ohio
$563K – – –
FQ
44
First Quadrant
California
$504K +$180K +4,015 +53%
CIBC Private Wealth Group
45
CIBC Private Wealth Group
Georgia
$502K +$4.94K +110 +1%
American Century Companies
46
American Century Companies
Missouri
$496K -$636K -14,152 -55%
TA
47
Teachers Advisors
New York
$438K – – –
D.E. Shaw & Co
48
D.E. Shaw & Co
New York
$413K +$180K +4,005 +72%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$403K -$45.3K -1,008 -10%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$386K -$7.82K -174 -2%
1
2
3 4

BSTC Hedge Fund Activity: Q4 2017 in Review

88 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2017, worth a combined $176M — down 6% from $187M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new BSTC positions and 10 closed out — a net gain of 1 holder — while 33 added to existing stakes and 34 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $7.85M. The largest seller was Northpointe Capital, cutting an estimated $2.47M.

  • 88 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2017, up from 87 in Q3 2017.
  • Funds reported $176M of BioSpecifics Technologies Corp. stock for Q4 2017, down 6% quarter-over-quarter.
  • 11 funds opened new BioSpecifics Technologies Corp. positions in Q4 2017 and 10 closed out, a net change of +1 holder.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2017 was Stonepine Capital Management, an estimated $7.85M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2017 was Northpointe Capital, an estimated $2.47M sold.

Based on aggregated 13F filings for Q4 2017.